AIDS2018: WHO recommends dolutegravir widely but women’s access will depend on contraception provision
WHO launched new interim guidance on HIV treatment at AIDS 2018 recommending dolutegravir (DTG) for everyone aged six years and above. [1, 2] But access to DTG for women and adolescent…